Skip to content

Effecacy and Safety of Hyperbaric Oxygen Therapy to patients with novel coronavirus pneumonia (COVID-19)

Effecacy and Safety of Hyperbaric Oxygen Therapy to patients with novel coronavirus pneumonia (COVID-19)

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000032011
Enrollment
Unknown
Registered
2020-04-17
Start date
2020-04-17
Completion date
Unknown
Last updated
2020-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

1.5ATA:1.5ATA HBO
2.5ATA:2.5ATA HBO
Control group:Routine treatment

Sponsors

Sixth Medical Center of PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >=18 years old; 2. Patients suspected of having COVID-2019 pneumonia who also have one of the following etiological or serological evidence: (1) Real-time fluorescent RT-PCR detection of COVID-2019 nucleic acid positive; (2) viral gene sequencing, and Known novel coronaviruses are highly homologous; (3) Serum novel coronavirus-specific IgM antibodies and IgG antibodies are positive; serum novel coronavirus-specific IgG antibodies change from negative to positive or the recovery period is 4 times higher than the acute period and increased high; 3. Ordinary patients have fever, respiratory tract and other symptoms, and imaging shows pneumonia; 4. Severe patients meet any of the following criterias: (1) Shortness of breath, RR330 times / min; (2) At rest, refers to oxygen saturation 50% were managed as heavy. 5. No contraindications to hyperbaric oxygen therapy; 6. The patient and his family can sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. pregnancy or lactation; 2. having a history of major diseases such as disorders of liver, kidney, endocrine or hematological systems; 3. coagulation disorder; 4. explicit history of tumors; 5. having a history of malnutrition and cachexia; 6. contraindicated by HBOT, such as pneumothorax, poor pressure adjustment of the eustachian tube, and internal hemorrhage; 7. Critically ill patients.

Design outcomes

Primary

MeasureTime frame
Oxygenation index;

Secondary

MeasureTime frame
Activity endurance;IL-6 level;Blood routine biochemical indicators;LUNG CT scan;microparticle;CRP;

Countries

China

Contacts

Public ContactShuyi Pan

Sixth Medical Center of PLA General Hospital

psy9992011@163.com+86 18600310183

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026